1. Home
  2. CVKD vs AGRZ Comparison

CVKD vs AGRZ Comparison

Compare CVKD & AGRZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cadrenal Therapeutics Inc.

CVKD

Cadrenal Therapeutics Inc.

N/A

Current Price

$1.71

Market Cap

3.4M

Sector

Health Care

ML Signal

N/A

Logo Agroz Inc. Ordinary Shares

AGRZ

Agroz Inc. Ordinary Shares

N/A

Current Price

$1.81

Market Cap

3.1M

ML Signal

N/A

Company Overview

Basic Information
Metric
CVKD
AGRZ
Founded
2022
2020
Country
United States
Malaysia
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Farming/Seeds/Milling
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
3.4M
3.1M
IPO Year
2022
2024

Fundamental Metrics

Financial Performance
Metric
CVKD
AGRZ
Price
$1.71
$1.81
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $14.00
N/A
AVG Volume (30 Days)
★ 103.3K
16.6K
Earning Date
11-16-2026
01-04-2027
Dividend Yield
N/A
N/A
EPS Growth
★ 23.94
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$4.15
Revenue Growth
N/A
N/A
52 Week Low
$0.82
$0.17
52 Week High
$12.50
$5.28

Technical Indicators

Market Signals
Indicator
CVKD
AGRZ
Relative Strength Index (RSI) 66.44 40.70
Support Level $0.88 $1.73
Resistance Level $2.23 $3.78
Average True Range (ATR) 0.21 0.25
MACD 0.07 -0.06
Stochastic Oscillator 78.44 37.97

Price Performance

Historical Comparison
CVKD
AGRZ

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and thrombotic conditions. Its product candidate, CAD-1005, is a first-in-class selective 12-LOX inhibitor being developed to treat heparin-induced thrombocytopenia (HIT), a deadly immune-mediated thrombotic disorder. The pipeline includes two additional clinical-stage assets: tecarfarin and frunexian. Tecarfarin is an oral vitamin K antagonist (VKA) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients requiring chronic anticoagulation. Frunexian is a first-in-class, Phase 2-ready intravenous Factor XIa inhibitor designed for acute care settings where contact activation of coagulation by medical devices or artificial surfaces.

About AGRZ Agroz Inc. Ordinary Shares

Agroz Inc is a vertically integrated agricultural technology (AgTech) company focused on designing, innovating, developing, building, operating and managing large, commercial-scale, industrial-grade indoor CEA vertical farms using CEA practices. Its mission is to improve food safety, food security, and sustainability for society by creating a reliable, accessible food supply through its AgTech products and services. CEA vertical farming is an agricultural method involving crop cultivation through vertically stacked layers in a controlled indoor environment. CEA practices are defined by growing produce in spaces where environmental conditions can be controlled and manipulated to match the needs of specific plants.

Share on Social Networks: